ProMIS Neurosciences (PMN) Short Interest Ratio & Short Volume → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free PMN Stock Alerts $1.98 +0.03 (+1.54%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media ProMIS Neurosciences Short Interest DataCurrent Short Volume23,100 sharesPrevious Short Volume23,800 sharesChange Vs. Previous Month-2.94%Dollar Volume Sold Short$50,127.00Short Interest Ratio / Days to Cover1.2Last Record DateApril 15, 2024Outstanding Shares18,961,000 sharesFloat Size14,360,000 sharesShort Percent of Float0.16%Today's Trading Volume1,032 sharesAverage Trading Volume16,702 sharesToday's Volume Vs. Average6% Short Selling ProMIS Neurosciences ? Sign up to receive the latest short interest report for ProMIS Neurosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPMN Short Interest Over TimePMN Days to Cover Over TimePMN Percentage of Float Shorted Over Time Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. ProMIS Neurosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202423,100 shares $50,127.00 -2.9%0.2%1.2 $2.17 3/31/202423,800 shares $45,458.00 -0.8%0.2%0.6 $1.91 3/15/202424,000 shares $45,840.00 +21.8%0.4%0.5 $1.91 2/29/202419,700 shares $41,173.00 +7.1%0.3%0.4 $2.09 2/15/202418,400 shares $35,880.00 -33.1%0.3%0.4 $1.95 1/31/202427,500 shares $55,000.00 No Change0.4%0.6 $2.00 6/15/2023200 shares $984.00 -33.3%N/A0.1 $4.92 5/31/2023300 shares $1,467.39 No ChangeN/A0.1 $4.89 5/15/2023300 shares $1,764.00 No ChangeN/A0.1 $5.88 PMN Short Interest - Frequently Asked Questions What is ProMIS Neurosciences' current short interest? Short interest is the volume of ProMIS Neurosciences shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 23,100 shares of PMN short. 0.16% of ProMIS Neurosciences' shares are currently sold short. Learn More on ProMIS Neurosciences' current short interest. What is a good short interest ratio for ProMIS Neurosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PMN shares currently have a short interest ratio of 1.0. Learn More on ProMIS Neurosciences's short interest ratio. What is a good short interest percentage for ProMIS Neurosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.16% of ProMIS Neurosciences' floating shares are currently sold short. Is ProMIS Neurosciences' short interest increasing or decreasing? ProMIS Neurosciences saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 23,100 shares, a decrease of 2.9% from the previous total of 23,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ProMIS Neurosciences' float size? ProMIS Neurosciences currently has issued a total of 18,961,000 shares. Some of ProMIS Neurosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ProMIS Neurosciences currently has a public float of 14,360,000 shares. How does ProMIS Neurosciences' short interest compare to its competitors? 0.16% of ProMIS Neurosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to ProMIS Neurosciences: JanOne Inc. (1.72%), Cara Therapeutics, Inc. (5.62%), Marker Therapeutics, Inc. (1.00%), Ocuphire Pharma, Inc. (6.37%), Unicycive Therapeutics, Inc. (1.53%), BriaCell Therapeutics Corp. (4.88%), Xilio Therapeutics, Inc. (4.35%), Bolt Biotherapeutics, Inc. (8.63%), NextCure, Inc. (0.54%), Apollomics, Inc. (0.32%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short ProMIS Neurosciences stock? Short selling PMN is an investing strategy that aims to generate trading profit from ProMIS Neurosciences as its price is falling. PMN shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ProMIS Neurosciences? A short squeeze for ProMIS Neurosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PMN, which in turn drives the price of the stock up even further. How often is ProMIS Neurosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PMN, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: JAN Short Interest Data CARA Short Interest Data MRKR Short Interest Data OCUP Short Interest Data UNCY Short Interest Data BCTX Short Interest Data XLO Short Interest Data BOLT Short Interest Data NXTC Short Interest Data APLM Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PMN) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlaceThe only accurate crypto trading system I know …Weiss Ratings